- Home
- SYRE vs ACEL Comparison
SYRE vs ACEL Comparison
Compare SYRE & ACEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- ACEL
- Stock Information
- Founded
- SYRE 2013
- ACEL 2009
- Country
- SYRE United States
- ACEL United States
- Employees
- SYRE N/A
- ACEL N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- ACEL Services-Misc. Amusement & Recreation
- Sector
- SYRE Health Care
- ACEL Consumer Discretionary
- Exchange
- SYRE Nasdaq
- ACEL Nasdaq
- Market Cap
- SYRE 1.1B
- ACEL 934.8M
- IPO Year
- SYRE 2016
- ACEL N/A
- Fundamental
- Price
- SYRE $15.86
- ACEL $11.26
- Analyst Decision
- SYRE Buy
- ACEL Buy
- Analyst Count
- SYRE 5
- ACEL 1
- Target Price
- SYRE $55.00
- ACEL $16.00
- AVG Volume (30 Days)
- SYRE 414.7K
- ACEL 326.6K
- Earning Date
- SYRE 11-06-2025
- ACEL 10-29-2025
- Dividend Yield
- SYRE N/A
- ACEL N/A
- EPS Growth
- SYRE N/A
- ACEL N/A
- EPS
- SYRE N/A
- ACEL 0.40
- Revenue
- SYRE N/A
- ACEL $1,279,563,000.00
- Revenue This Year
- SYRE N/A
- ACEL $9.99
- Revenue Next Year
- SYRE N/A
- ACEL $5.17
- P/E Ratio
- SYRE N/A
- ACEL $28.42
- Revenue Growth
- SYRE N/A
- ACEL 7.00
- 52 Week Low
- SYRE $10.91
- ACEL $9.02
- 52 Week High
- SYRE $40.26
- ACEL $13.28
- Technical
- Relative Strength Index (RSI)
- SYRE 42.99
- ACEL 45.34
- Support Level
- SYRE $15.80
- ACEL $10.99
- Resistance Level
- SYRE $17.58
- ACEL $11.41
- Average True Range (ATR)
- SYRE 0.74
- ACEL 0.25
- MACD
- SYRE -0.11
- ACEL 0.01
- Stochastic Oscillator
- SYRE 9.78
- ACEL 30.91
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.